A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset

dc.authorscopusid6601988964
dc.authorscopusid7005152947
dc.authorscopusid35584298800
dc.authorscopusid58685662800
dc.authorscopusid55767240300
dc.authorscopusid55357185100
dc.authorscopusid35474297200
dc.contributor.authorAltiok,E.
dc.contributor.authorAksoy,F.
dc.contributor.authorPerk,Y.
dc.contributor.authorTaylan,F.
dc.contributor.authorKim,P.W.
dc.contributor.authorIlkkan,B.
dc.contributor.authorSanal,O.
dc.date.accessioned2024-05-25T12:31:12Z
dc.date.available2024-05-25T12:31:12Z
dc.date.issued2012
dc.departmentOkan Universityen_US
dc.department-tempAltiok E., Department of Medical Biology, Acibadem University Faculty of Medicine, Istanbul, Turkey, Department of Genetics and Bioengineering, Okan University, Tuzla, Istanbul 34959, Turkey; Aksoy F., Department of Pathology, Cerrahpasa Medical School, Istanbul, Turkey; Perk Y., Neonatology Unit, Cerrahpaşa Medical School, stanbul, Turkey; Taylan F., Acibadem Genetika, Istanbul, Turkey; Kim P.W., National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, United States; Ilkkan B., Neonatology Unit, Cerrahpaşa Medical School, stanbul, Turkey; Asal G.T., Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey; Goldbach-Mansky R., National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, United States; Sanal O., Division of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkeyen_US
dc.description.abstractDeficiency of the IL-1 receptor antagonist (DIRA) is a recently described rare autoinflammatory disease, caused by loss of function mutations in IL1RN leading to the unopposed activation of the IL-1 pathway. We describe a novel nonsense mutation in the IL1RN gene, associated with early intrauterine onset, death and multiorgan involvement in a prematurely born baby. The protein prediction model indicated that the novel Q119X mutation would result in a nonfunctional protein by impairing the ability of the IL-1Ra to bind and antagonize signaling through the IL-1R. Since the disorder may mimic severe bacterial infections and the treatment with anakinra is life saving, we intend to raise awareness of the syndrome and the possibility of a founder mutation that may lead to the diagnosis of additional cases in Turkey. The clinical suspicion of DIRA is critical to avoid improper management of the patients with antibiotics alone and death from multiorgan failure. © 2012 Elsevier Inc.en_US
dc.description.sponsorshipNational Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS, (ZIDAR041180)en_US
dc.identifier.citation45
dc.identifier.doi10.1016/j.clim.2012.08.003
dc.identifier.endpage81en_US
dc.identifier.issn1521-7035
dc.identifier.issue1en_US
dc.identifier.pmidPubMed:22940634
dc.identifier.scopus2-s2.0-84865474221
dc.identifier.scopusqualityQ1
dc.identifier.startpage77en_US
dc.identifier.urihttps://doi.org/10.1016/j.clim.2012.08.003
dc.identifier.urihttps://hdl.handle.net/20.500.14517/2265
dc.identifier.volume145en_US
dc.language.isoen
dc.relation.ispartofClinical Immunologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAutoinflammatory syndromeen_US
dc.subjectDeficiency of interleukin-1 receptor antagonisten_US
dc.subjectImmunodeficiencyen_US
dc.subjectIntrauterine onseten_US
dc.titleA novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onseten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files